KFDA to introduce Phase zero(0) clinical trial guideline

The Korea Food and Drug Administration unveiled its plan to formulate a guideline for Phase zero(0) clinical trial as part of efforts to facilitate rational drug selection, identify therapeutic failures early, and compress timelines for anticancer drug development.

The drug agency also said that because the toxicology testing required prior to initiating Phase 0 clinical trials is reduced du...